Adaptimmune

Adaptimmune is a clinical-stage biopharmaceutical company that develops engineered T-cell therapies to treat various forms of cancer. The company utilizes its proprietary cell therapy platform to design treatments such as TECELRA, afami-cel, and uza-cel, which are engineered to target specific solid tumors. Its primary focus is on arming the immune system's cells to identify and eliminate cancerous cells in patients with high unmet medical needs.